Vivian Wu | executive |
Howard W. Robin | executive |
Jonathan Zalevsky | executive |
Jennifer Ruddock | executive |
Jay Olson | analyst |
Mary Tagliaferri | executive |
Jiale Song | analyst |
Elias Lenard | analyst |
Tsan-Yu Hsieh | analyst |
Good day, and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2024 Financial Results Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Vivian Wu.